Nice find @NZ Trader
Interesting to see that Remdesivir and Molnupiravir work on a different aspect of the virus than MPL, so they can be considered allies rather than competitors in our commercialisation pathway.
Ann: Monepantel and monepantel sulfone COVID-19 anti-viral update, page-74
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $97.32M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $32.55K | 166.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 250876 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 98968 | 3 |
View Market Depth
| Last trade - 12.09pm 03/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |